电邮这篇文章 Studying of the Mechanisms of Combined Effect of Dexamethasone, Doxorubicin, and Docetaxel on Breast Cancer Cells
- 作者: Dukhanina E.A.1, Portseva T.N.1,2, Dukhanin A.S.2, Georgieva S.G.1
-
隶属关系:
- V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
- 期: 卷 166, 编号 1 (2018)
- 页面: 54-57
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240828
- DOI: https://doi.org/10.1007/s10517-018-4288-2
- ID: 240828
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
The sensitivity of MDA-MB231 breast cancer cells to the effects of pharmacological agents was evaluated by their motility and viability. Dexamethasone, doxorubicin, or docetaxel administered separately in their effective concentration suppressed cell motility (in 16 h) and caused cell death (in 48 h). The strength of the effects increased in the following order: dexa methasone
作者简介
E. Dukhanina
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
编辑信件的主要联系方式.
Email: das03@rambler.ru
俄罗斯联邦, Moscow
T. Portseva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
俄罗斯联邦, Moscow; Moscow
A. Dukhanin
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
俄罗斯联邦, Moscow
S. Georgieva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Email: das03@rambler.ru
俄罗斯联邦, Moscow
补充文件
